EUCALIA Inc.
Stock Price Chart
2026/09/21 UpdatedPrice Trend
2026/09/21 UpdatedPrice & Trading Details
2026/09/21 UpdatedPRICE
TRADING
Analyst Recommendations 1 analysts
Updated 2026/09/01Shareholder Composition
Updated 2026/09/01Financial Performance
2026/09/20 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥16,616M | ¥18,055M | ¥19,834M | ¥24,735M |
| Gross Profit | ¥5,809M | ¥7,106M | ¥8,692M | ¥10,537M |
| Operating Income | ¥866M | ¥1,900M | ¥2,293M | ¥2,365M |
| Pretax Income | ¥1,523M | ¥1,962M | ¥3,401M | ¥3,428M |
| Net Income | ¥980M | ¥1,051M | ¥2,026M | ¥2,776M |
| EPS | ¥27.82 | ¥35.18 | ¥63.12 | ¥76.75 |
| Operating Margin | 5.21% | 10.52% | 11.56% | 9.56% |
| Balance Sheet | ||||
| Total Assets | ¥42,631M | ¥50,985M | ¥60,148M | ¥65,126M |
| Total Equity | ¥9,696M | ¥10,820M | ¥17,960M | ¥20,518M |
| Total Liabilities | ¥32,935M | ¥40,164M | ¥42,188M | ¥44,608M |
| Cash | ¥6,165M | ¥6,724M | ¥11,169M | ¥9,086M |
| Interest-bearing Debt | ¥20,504M | ¥26,874M | ¥27,217M | ¥29,321M |
| Equity Ratio | 22.74% | 21.22% | 29.86% | 31.50% |
| D/E Ratio | 2.11 | 2.48 | 1.52 | 1.43 |
| Cash Flow | ||||
| Operating CF | ¥2,660M | -¥209M | ¥1,301M | -¥1,878M |
| Investing CF | ¥1,412M | -¥5,583M | -¥406M | -¥2,275M |
| Financing CF | -¥5,019M | ¥6,341M | ¥3,548M | ¥1,830M |
| Free CF | ¥1,736M | -¥5,247M | -¥53M | -¥2,799M |
| Efficiency | ||||
| ROE | 10.11% | 9.72% | 11.28% | 13.53% |
| ROA | 2.30% | 2.06% | 3.37% | 4.26% |
Latest IR Information
-
No IR information found for this company.
Searched stock code: 286A
Latest News (5 items)
-
Average Analyst Rating: none
Average Target Price: ¥900
Rating Score: - (Based on 1 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
EUCALIA Inc. offers hospital management support services in Japan. The company offers consulting on organizational restructuring and business succession for medical institutions; plans, designs, and constructs building and structures; and manages, consults and introduces elderly care facilities. It also manufactures and sells contact lens and designs, develops, sells, and maintains package systems. EUCALIA Inc. was formerly known as Capital Medica Co., Ltd and changed its name to EUCALIA Inc. in May 2022. The company was founded in 2005 and is headquartered in Tokyo, Japan.
